Reeve Bryce B, McFatrich Molly, Pinheiro Laura C, Freyer David R, Basch Ethan M, Baker Justin N, Withycombe Janice S, Sung Lillian, Mack Jennifer W, Waldron Mia K, Mowbray Catriona, Palma Diana, Hinds Pamela S
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA; Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
J Pain Symptom Manage. 2017 Apr;53(4):759-766. doi: 10.1016/j.jpainsymman.2016.11.006. Epub 2017 Jan 3.
The National Cancer Institute created the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) to allow direct input on symptomatic adverse events (AEs) from adult patients in oncology trials.
This study sought to determine the youngest age to complete the PRO-CTCAE, evaluated comprehension of PRO-CTCAE among adolescents, tested new items not currently in PRO-CTCAE, and tested a parent-proxy version.
From seven pediatric cancer hospitals, 51 adolescents (13-20 years) receiving cancer treatment participated, along with 40 parent proxies. We evaluated 55 AEs from the PRO-CTCAE library (97 questions) and seven new AEs not in PRO-CTCAE that assess symptom frequency, severity, interference, or presence. Questions were distributed across three forms to reduce burden. Cognitive interviews with retrospective probing were completed in age groups of 13-15 and 16-20 year olds. Proxies were interviewed independently.
In general, the 16-20 year olds and the parent proxies were able to understand and complete the PRO-CTCAE and newly designed AE questions. Five PRO-CTCAE terms (bloating of the abdomen, anxiety, flashing lights in front of your eyes, hot flashes, and bed sores) and the wording of the questions about AE severity were challenging for a few adolescents and proxies. The 13-15 year olds had greater challenges completing the PRO-CTCAE.
This study extends use of the adult PRO-CTCAE for adolescents as young as 16 years and proposes new questions for seven new symptomatic AEs and a parent-proxy version of PRO-CTCAE. Additional testing of the new questions and alternative language for more challenging PRO-CTCAE items is recommended in adults.
美国国立癌症研究所创建了不良事件通用术语标准的患者报告结局版本(PRO-CTCAE),以便肿瘤学试验中的成年患者能够直接报告症状性不良事件(AE)。
本研究旨在确定能够完成PRO-CTCAE的最小年龄,评估青少年对PRO-CTCAE的理解,测试目前不在PRO-CTCAE中的新项目,并测试家长代理版本。
来自7家儿科癌症医院的51名接受癌症治疗的青少年(13 - 20岁)以及40名家长代理人参与了研究。我们评估了PRO-CTCAE库中的55种不良事件(97个问题)以及7种不在PRO-CTCAE中的新不良事件,这些事件用于评估症状频率、严重程度、干扰或是否存在。问题分布在三种表格中以减轻负担。对13 - 15岁和16 - 20岁年龄组的青少年进行了带有回顾性探查的认知访谈。对家长代理人进行了单独访谈。
总体而言,16 - 20岁的青少年和家长代理人能够理解并完成PRO-CTCAE以及新设计的不良事件问题。有几个青少年和家长代理人对5个PRO-CTCAE术语(腹部胀气、焦虑、眼前闪光、潮热和褥疮)以及关于不良事件严重程度问题的措辞感到困惑。13 - 15岁的青少年在完成PRO-CTCAE方面面临更大挑战。
本研究将成人PRO-CTCAE的使用扩展到了16岁及以上的青少年,并针对7种新的症状性不良事件提出了新问题以及PRO-CTCAE的家长代理版本。建议在成人中对新问题以及更具挑战性的PRO-CTCAE项目的替代措辞进行进一步测试。